WASHINGTON (dpa-AFX) - C. R. Bard, Inc. (BCR) said the results from its
LEVANT 2 study has demonstrated superior primary patency for Lutonix 035 Drug
Coated Balloon PTA Catheter over standard percutaneous transluminal angioplasty
or PTA, as well...
National PTA®, the nation's oldest and largest child advocacy association, and LifeLock, Inc. (NYSE: LOCK), a leader in proactive identity theft protection, today announced the next phase of their joint campaign to empower families to make...
Oops! Unable to complete your request. Please refresh your browser.
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article.